Source: Eur Respir J 2015; 45: 1179-1182
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Morris Norman R., Seale Helen, Harris Julie, Hall Kathleen, Hopkins Peter, Kermeen Fiona. Serious adverse events during a 6-min walk test in patients with pulmonary hypertension. Eur Respir J 2015; 45: 1179-1182

Member's Comments

No comment yet.

Related content which might interest you: Six-minute walk test correlates with hemodynamic severity in chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2004; 24: Suppl. 48, 111s Year: 2004 Spiroveloergometry and 6-minute walking test for exercise capacity assessment in patients with primary pulmonary hypertension Source: Eur Respir J 2005; 26: Suppl. 49, 16s Year: 2005 Using the six-minute walk test to assess exercise capacity in people with pulmonary hypertension Source: Annual Congress 2012 - Assessment of physical activity, exercise, muscle function and clinical characteristics as outcomes in physiotherapy and rehabilitation Year: 2012 Oxygen desaturation in 6-min walk test is a risk factor for adverse outcomes in COPD Source: Eur Respir J 2016; 48: 82-91 Year: 2016 The role of per cent predicted 6-min walk distance in pulmonary arterial hypertension Source: Eur Respir J 2010; 36: 1294-1301 Year: 2010 Relationship between sit-to-stand test and six-minute walk test in patients with pulmonary arterial hypertension Source: International Congress 2015 – The challenge of choosing the best physical and functional assessment methods Year: 2015 The influence of selected sociodemographic parameters on the results of 6-minute walk test (6MWT) in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 243s Year: 2004 The cardiovascular and dyspnea response to the six minute and shuttle walk tests in COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 406s Year: 2003 The need to move from 6-minute walk distance to outcome trials in pulmonary arterial hypertension Source: Eur Respir Rev 2013; 22: 487-494 Year: 2013 Physiological responses to the 6-min walk test in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: 564-569 Year: 2002 Exercise testing to predict outcome in idiopathic versus associated pulmonary arterial hypertension Source: Eur Respir J 2012; 40: 1410-1419 Year: 2012 Dynamic hyperinflation during the 6-minute walk test and incremental cycling exercise in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 121s Year: 2004 Physiological response to the six-minute walk test in pulmonary arterial hypertension Source: Eur Respir J 2005; 26: 667-672 Year: 2005 The clinical relevance of heart rate increase in the interpretation of six-minute walk test in pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology Year: 2012 Cardiopulmonary exercise testing, six minute walk and hemodynamics in patients with chronic thromboembolic pulmonary hypertension (CTEPH) Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases Year: 2008 Maximal cardiopulmonary exercise testing in mildly symptomatic patients with idiopathic pulmonary arterial hypertension: correlations with 6-min walk distance and resting hemodynamics Source: Annual Congress 2009 - Pulmonary vascular diseases Year: 2009 Predictors of oxygen desaturation in the six-minute walk test in COPD patients Source: Annual Congress 2009 - Novel insights in exercise physiology from cells to humans Year: 2009 Interpretation of treatment changes in 6-minute walk distance in patients with COPD Source: Eur Respir J 2008; 32: 637-643 Year: 2008 Comparison of cardiorespiratory variables evaluted during shuttle and six-minute walk tests in chronic renal failure patients Source: Eur Respir J 2007; 30: Suppl. 51, 654s Year: 2007 Reproducibility of 6-minute walking test in patients with COPD Source: Eur Respir J 2011; 38: 261-267 Year: 2011